Degussa opens bio science centre

“White biotechnology” is the term applied to industrial manufacturing
processes that are based primarily on natural biological resources. These
biotechnologically based production processes, in addition to consuming smaller
amounts of raw materials and energy, also produce less waste and fewer
by-products; they therefore offer alternatives, which are highly promising from
both the ecological and economic viewpoints, to conventional chemical and
physical processes.

“White biotechnology is one of the most important key
technologies for the chemical industry. We can use its toolbox not only to
replace the classical petrochemical methods but also to develop products with
entirely new properties. This opens the door for Degussa to develop innovative
products with high added value and new businesses in attractive markets,” says
Dr. Alfred Oberholz, deputy chairman of Degussa’s Management
Board.

Research focus
The Science-to-Business Center will focus
on, among other things, research for surface coatings and drug delivery systems
that, in addition to other advantageous properties, are very well tolerated by
the body. Research is also being carried out on pharmaceutical active
ingredients and protective ingredients for creams and lotions. Degussa is
already well advanced in using bioprocesses to manufacture pharmaceutical amino
acids for infusion solutions, amino acids for animal nutrition, and specialty
building blocks for drugs.

Investments
Degussa will
invest about €50 million in the Science-to-Business Centre over a period of five
years. The state of NRW will support the future-oriented technologies to be
developed there with a grant of €11.3 million, co-financed by the European
Union. The German government will also support the Centre to the tune of €7
million.

Related website:
Degussa

To receive the
AllAboutFeed newsletter click here.